Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 28;11(9):1680.
doi: 10.3390/antiox11091680.

Role of Cholesterol in the Regulation of Hydrogen Sulfide Signaling within the Vascular Endothelium

Affiliations

Role of Cholesterol in the Regulation of Hydrogen Sulfide Signaling within the Vascular Endothelium

Perenkita J Mendiola et al. Antioxidants (Basel). .

Abstract

H2S is a gaseous signaling molecule enzymatically produced in mammals and H2S-producing enzymes are expressed throughout the vascular wall. We previously reported that H2S-induced vasodilation is mediated through transient receptor potential cation channel subfamily V member 4 (TRPV4) and large conductance (BKCa) potassium channels; however, regulators of this pathway have not been defined. Previous reports have shown that membrane cholesterol limits activity of TRPV4 and BKCa potassium channels. The current study examined the ability of endothelial cell (EC) plasma membrane (PM) cholesterol to regulate H2S-induced vasodilation. We hypothesized that EC PM cholesterol hinders H2S-mediated vasodilation in large mesenteric arteries. In pressurized, U46619 pre-constricted mesenteric arteries, decreasing EC PM cholesterol in large arteries using methyl-β-cyclodextrin (MBCD, 100 µM) increased H2S-induced dilation (NaHS 10, 100 µM) but MBCD treatment had no effect in small arteries. Enface fluorescence showed EC PM cholesterol content is higher in large mesenteric arteries than in smaller arteries. The NaHS-induced vasodilation following MBCD treatment in large arteries was blocked by TRPV4 and BKCa channel inhibitors (GSK219384A, 300 nM and iberiotoxin, 100 nM, respectively). Immunohistochemistry of mesenteric artery cross-sections show that TRPV4 and BKCa are both present in EC of large and small arteries. Cholesterol supplementation into EC PM of small arteries abolished NaHS-induced vasodilation but the cholesterol enantiomer, epicholesterol, had no effect. Proximity ligation assay studies did not show a correlation between EC PM cholesterol content and the association of TRPV4 and BK. Collectively, these results demonstrate that EC PM cholesterol limits H2S-induced vasodilation through effects on EC TRPV4 and BKCa channels.

Keywords: endothelial cell; methyl-β-cyclodextrin; microdomains.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
H2S-induced vasodilation in rat and mouse mesenteric arteries. Representative traces and data summary of H2S-induced vasodilation following cholesterol reduction with MβCD (100 μM) in rat large arteries (AC). Mean ± S.D. * p = 0.026 vs. vehicle; **** p < 0.0001 vs. vehicle and rat small arteries (DF). Mean ± S.D. (GH). H2S-induced vasodilation in mouse large and small mesenteric arteries. Mean ± S.D. * p = 0.01, ** p = 0.0011 vs. large, two-way ANOVA with Sidak’s multiple comparison test.
Figure 2
Figure 2
Cholesterol content in large (>200 μm) and small (<200 μm) mesenteric arteries. (A). Representative en face images of cholesterol marker, filipin III (green, 20 μg/mL) and endothelial glycoprotein marker Lectin (red, 20 μg/mL) acquired at 63x with additional digital zoom of small artery for visualization of cells. Nuclei are labeled with SYTOX (blue). (B). Mean ± S.D. *** p = 0.0004, unpaired t test.
Figure 3
Figure 3
Representative traces and data summary of H2S-induced vasodilation under (A). vehicle (Veh) condition or following (B). epicholesterol (Epi, 20 μM) or (C). cholesterol (Chol, 28 μM) supplementation into EC PM of small mesenteric arteries. Summary data of H2S dilation in cholesterol and epicholesterol treated small arteries (D) Mean ± S.D. * p = 0.04, ** p = 0.0012, **** p < 0.001, one-way ANOVA with Sidak’s multiple comparison test.
Figure 4
Figure 4
H2S-induced vasodilation following cholesterol reduction in large arteries is mediated by activation of TRPV4 and BK channels. (A). Representative images of EC PM TRPV4 and BK (green), endothelial glycoprotein marker Lectin (red) in cross-sections of large and small mesenteric arteries. Nuclei are labeled with SYTOX (blue). “NO 1°” shows the no primary Ab negative controls. Representative traces and data summary of H2S-mediated vasodilation following cholesterol reduction (B) in large arteries in the presence of BK inhibitor iberiotoxin ((C), Ibtx, 100 nM) or TRPV4 inhibitor GSK 2193874 ((D), GSK, 300 nM) Summary data of H2S-induced dilation in cholesterol depleted arteries (E). Mean ± S.D. **** p < 0.0001 vs. control, one-way ANOVA with Sidak’s multiple comparison test.
Figure 5
Figure 5
Endothelial TRPV4 and BK association in large and small mesenteric arteries following sterol manipulation. (A). Representative images of mesenteric artery cross-sections with endothelial glycoprotein marker Lectin (green) and PLA puncta for TRPV4/BK association (red). Nuclei are labeled with SYTOX (blue). (B). Number (#) of puncta count /total area and (C). area of puncta from 23 arteries/size group per animal. Mean ± S.D. n = 4 animals/group. (D). Primary antibodies without ligation or amplification (+Prim/No Amp); inclusion of BK but not TRPV4 primary antibody with ligation and amplification (+BK/-TRPV4/+Amp); and No primary No amplification as negative controls.

References

    1. Hosoki R., Matsuki N., Kimura H. The Possible Role of Hydrogen Sulfide as an Endogenous Smooth Muscle Relaxant in Synergy with Nitric Oxide. Biochem. Biophys. Res. Commun. 1997;237:527–531. doi: 10.1006/bbrc.1997.6878. - DOI - PubMed
    1. Peake B.F., Nicholson C.K., Lambert J.P., Hood R.L., Amin H., Amin S., Calvert J.W. Hydrogen Sulfide Preconditions the Db/Db Diabetic Mouse Heart against Ischemia-Reperfusion Injury by Activating Nrf2 Signaling in an Erk-Dependent Manner. Am. J. Physiol. Heart Circ. Physiol. 2013;304:H1215–H1224. doi: 10.1152/ajpheart.00796.2012. - DOI - PMC - PubMed
    1. Polhemus D.J., Li Z., Pattillo C.B., Gojon G., Gojon G., Giordano T., Krum H. A Novel Hydrogen Sulfide Prodrug, SG1002, Promotes Hydrogen Sulfide and Nitric Oxide Bioavailability in Heart Failure Patients. Cardiovasc. Ther. 2015;33:216–226. doi: 10.1111/1755-5922.12128. - DOI - PMC - PubMed
    1. Shi S., Li Q., Li H., Zhang L., Xu M., Cheng J., Peng C., Xu C., Tian Y. Anti-Apoptotic Action of Hydrogen Sulfide Is Associated with Early JNK Inhibition. Cell Biol. Int. 2009;33:1095–1101. doi: 10.1016/j.cellbi.2009.06.029. - DOI - PubMed
    1. Wallace J.L., Vaughan D., Dicay M., MacNaughton W.K., de Nucci G. Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic. Antioxid. Redox Signal. 2018;28:1533–1540. doi: 10.1089/ars.2017.7068. - DOI - PubMed

LinkOut - more resources